Home > Healthcare > Medical Devices > Diagnostic Devices > Metabolism Assays Market

Metabolism Assays Market Size

  • Report ID: GMI7672
  • Published Date: Dec 2023
  • Report Format: PDF

Metabolism Assays Market Size

Metabolism Assays Market was valued at around USD 1.5 billion in 2023 and is estimated to witness 7.6% CAGR from 2024 to 2032. The rising prevalence of chronic diseases along with the growing demand for personalized medicines is anticipated to drive the market growth globally.

 

Chronic diseases such as diabetes, obesity, cancer, and cardiovascular diseases among others are serious medical conditions that significantly impact the daily lives and well-being of affected individuals. For instance, according to the Centers for Disease Control and Prevention, in 2022, 38.4 million Americans, or 11.6% of the U.S. population had diabetes. Metabolism assays, focusing on the analysis of glucose metabolism, insulin sensitivity, and the functionality of pancreatic beta cells, play a crucial role in unravelling the biochemical processes associated with diabetes. These assays provide essential insights into the molecular and cellular aspects of metabolic regulation, contributing significantly to understanding the pathophysiology of such chronic conditions.
 

Metabolism assays refer to laboratory techniques and procedures designed to investigate and quantify the chemical processes that occur within cells and organisms. These assays are specifically geared towards understanding metabolic pathways, energy utilization, and the production and consumption of various metabolites.
 

The presence of alternative methods and techniques is among the major factors that may hamper the adoption of metabolism assays. The ongoing advancements in technology, particularly in the field of omics such as metabolomics, genomics services, and proteomics, provides researchers and laboratories with alternatives for exploring cellular metabolism. These sophisticated approaches offer a more extensive and detailed perspective on cellular functions and metabolic pathways. These alternatives can provide researchers with a more holistic view of cellular metabolism compared to traditional assays.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Metabolism assays industry size was worth USD 1.5 billion in revenue in 2023 and is projected to exceed USD 2.9 billion by 2032 driven by the rising prevalence of chronic diseases along with the growing demand for personalized medicines.

Metabolism assays industry from the assay kits & reagents segment generated USD 944.5 million in 2023 and is likely to witness high demand through 2032 owing to its increasing application in studying glucose metabolism, lipid metabolism, enzymatic activities, and other metabolic processes.

U.S. metabolism assays industry size is set to surpass USD 1.2 billion by the end of 2032 attributed to the rising prevalence of chronic diseases, supportive government initiatives, and technological advancements among others.

Some of the top metabolism assay companies are Merck KGaA, Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Promega Corporation, Kaneka Eurogentec S.A (Kaneka Corporation), RayBiotech Life, Inc., BMG Labtech, and Biotrend Chemikalien GmbH, among others.

Metabolism Assays Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 11
  • Tables & Figures: 338
  • Countries covered: 22
  • Pages: 180
 Download Free Sample